iVeena

Large logo of iVeena

Headquarters

Flag of United States of AmericaUnited States of America

iVeena Delivery Systems, Inc. (iVeena) is an independently owned, preclinical stage biopharmaceutical organization concentrating on broadening its platform technology for non-surgical, drug-related corneal flattening to create products that cater to unmet healthcare needs in the field of ophthalmology. The primary focus of the company is on IVMED-80, an innovative therapy for keratoconus. Additionally, iVeena is in the process of developing IVMED-85 and IVMED-95 for addressing pediatric high myopia and adult low myopia respectively.